Technology
Applications
Resources
Support
Company
Contact
EN
EN
- Global
CN
- 中国
menu
Close
Home
Technology
Applications
Pharmacogenetics
Liquid Biopsy
Mutation Profiling
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Home
Technology
Applications
Pharmacogenetics
Mutation Profiling
Liquid Biopsy
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Phone: (858) 882-2800
Home
/
Resources
/
Publication Library
Search Results for: Mutation Profiling
Search All publications
How recent?
Search
Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinib
Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report
Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction
Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response
BRAFV600E and NRASQ61L/Q61R mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting
Oncogene Mutation Profiling Reveals Poor Prognosis Associated with FGFR1/3 Mutation in Liposarcoma
Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients
The impact of intermittent versus continuous exposure to EGFR tyrosine kinase inhibitor on selection of EGFR T790M-mutant drug-resistant clones in a lung cancer cell line carrying activating EGFR mutation
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
«
...
10
20
30
...
36
37
38
39
40
...
50
...
»